For hospitals, value-based care could actually equal lower readmission rates

Dollar coins in the box.

In recent years, there’s been much hullabaloo surrounding value-based care. Are value-based initiatives truly effective? Are they helping or harming physicians? How do things change when you add telehealth to the equation?

A recent study in JAMA Internal Medicine outlined a few positive gains for value-based care initiatives and their effect on hospitals. The study found hospitals participating in one or more value-based programs have lower readmission rates.

As part of the study, researchers analyzed 2,837 U.S. hospitals between 2008 and 2015. The researchers used publicly available national data from Hospital Compare to look at the hospitals’ 30-day readmission rates for patients with heart attacks, heart failure and pneumonia.

Specifically, they assessed the hospitals’ participation in three voluntary value-based care programs: Meaningful Use, bundled payments and accountable care organizations. “We used an interrupted time series design to test whether hospitals’ time-varying participation in these value-based reforms was associated with greater improvement in Medicare’s [Hospital Readmission Reduction Program],” the researchers wrote.

Because the researchers analyzed the hospitals over a seven-year period, one of their primary findings involves a drastic change in the number of hospitals participating in value-based programs. In 2010, none of the 2,837 hospitals were participating in Meaningful Use, bundled payment or ACO programs. But five years later, 2,781 hospitals were participating in at least one of the programs.

By Erin Dietsche | MedCity News

Photo Credit: Hong Li, Getty Images


About Peter Coffaro 629 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.